Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in UNITED STATES :
Bayer AG
(2019
sales of $48.67 billion
of which 46%
was CropScience),
Merck & Co. , Inc.
($46.84 billion
of which 89%
was Merck Pharmaceutical), and
Novartis AG
($48.62 billion
of which 78%
was Innovative Medicines).
Sales Analysis.
During the year ended December of 2019, sales at
Pfizer Inc. were $51.75 billion.
This
is
a
decrease of 3.5%
versus 2018, when the company's sales were $53.65 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Pfizer Inc. had sales
of $49.61 billion.